|
|
||||||||
J Thorac Cardiovasc Surg 2008;135:901-907
© 2008 The American Association for Thoracic Surgery
Surgery for Acquired Cardiovascular Disease |
a Department of Cardiothoracic Surgery, Stanford University Medical School, Stanford, Calif
b Department of Radiology, Stanford University Medical School, Stanford, Calif
c Cardiovascular Medicine Division, Stanford University Medical School, Stanford, Calif
Received for publication August 2, 2007; revisions received December 22, 2007; accepted for publication January 23, 2008. * Address for reprints: D. Craig Miller, MD, Department of Cardiothoracic Surgery, Falk Cardiovascular Research Center, Stanford University School of Medicine, Stanford, California 94305-5247. (Email: dcm{at}stanford.edu).
| Abstract |
|---|
|
|
|---|
Methods: Sixty-four patients with bicuspid aortic valves who underwent computed tomographic or magnetic resonance angiography and echocardiography were retrospectively identified between January 2002 and March 2006. Orthonormal 2–dimensional or 3-dimensional aortic diameters were measured at 10 levels. Agglomerative hierarchic clustering with centered correlation distance measurements and complete linkage analysis was used to detect distinct patterns of aortic dilatation.
Results: Mean aortic diameter was 28.1 ± 0.7 mm at the annulus and 21.7 ± 0.4 mm at the diaphragmatic hiatus. The aorta was largest in the tubular ascending aorta (45.9 ± 1.0 mm). Compared with the descending aorta, the transverse aortic arch was also dilated (P < .01). Cluster analysis showed 4 patterns of aortic dilatation: cluster I, aortic root alone (n = 8, 13%); cluster II, tubular ascending aorta alone (n = 9, 14%); cluster III, tubular portion and transverse arch (n = 18, 28%); and, cluster IV, aortic root and tubular portion with tapering across the transverse arch (n = 29, 45%).
Conclusion: Distinct patterns of aortic dilatation in patients with bicuspid aortic valves call for an individualized degree of aortic replacement to minimize late aortic complications and reoperation. Patients in clusters III and IV should have transverse arch replacement (plus concomitant root replacement in cluster IV). Patients in cluster I should undergo complete aortic root replacement, whereas in patients in cluster II supracommissural ascending aortic grafting is adequate.
| Introduction |
|---|
|
|
|---|
The most important clinical consequence of an enlarged ascending aorta and the underlying aortopathy is the higher incidence of aortic rupture and aortic dissection. The presence of a BAV increases the risk of aortic dissection 9-fold and puts the patient at risk of aortic dissection at a younger age.12,13
Notably, aortic dissection usually occurs in the presence of a normally functioning BAV.12,14
Although it is clear that BAV disease is associated with proximal aortic dilation, controversy exists concerning the extent of thoracic aortic involvement, mainly because the majority of studies to date have only used echocardiography to detect aortic dilatation.15
Herein we document thoracic aortic morphology in patients with BAVs using computed tomographic angiography (CTA) or magnetic resonance angiography (MRA). We then used hierarchic clustering, a tool used to automatically detect data clusters in gene-array studies,16
to identify 4 distinct patterns of aortic involvement. These 4 distinct clusters argue that a custom-tailored surgical approach is most appropriate in dealing with the dilated aorta in the setting of a BAV.
| Materials and Methods |
|---|
|
|
|---|
Thoracic aortic diameter was measured at 10 levels: (1) aortic annulus, (2) sinuses of Valsalva, (3) sinotubular junction, (4) tubular portion of the ascending aorta, (5) proximal to the innominate artery (or common trunk in case of a bovine arch), (6) distal to the innominate artery (or common trunk), (7) proximal to the left subclavian artery, (8) distal to the left subclavian artery, (9) proximal descending aorta, and (10) distal descending thoracic aorta at the level of the diaphragmatic hiatus (
Figure 1). Aortic measurements were made in the orthonormal plane to the aorta by using 3-dimensional (3-D) reconstructions of the thoracic aorta or 2-dimensional (2-D) axial images when 3-D images were not available. Measurements from the 3-D images were obtained in arbitrary pixels that were converted to metric measurements by normalizing to the aortic diameter measured at the diaphragmatic hiatus on both the 3-D and 2-D axial images. This aortic level was chosen for determining the correction factor because the 2-D axial cuts are most likely to be orthonormal to the longitudinal axis of the descending thoracic aorta here in these young patients. Correlation between the 3-D and 2-D axial measurements was determined in 10 randomly selected patients who had both sets of images available for analysis. Interobserver variability was determined by comparing measurements made by 2 independent blinded observers in another 10 randomly chosen patients.
|
| Results |
|---|
|
|
|---|
A mean aortic valve gradient of greater than 10 mm Hg (aortic stenosis) was present in 39% (24/62) of patients for whom echocardiographic reports were available. The distribution of aortic gradients was as follows: 10 to 25 mm Hg, n = 11; 26 to 50 mm Hg, n = 10; and greater than 50 mm Hg, n = 3. The mean aortic valve gradient in patients who had any flow acceleration across the valve (n = 42) was 21.6 ± 3.2 mm Hg. Thirty-nine patients had aortic insufficiency (AI), which was distributed as follows: 1+ AI, n = 13; 2+ AI, n = 15; 3+ AI, n = 9; and 4+ AI, n = 2. In patients with AI, the direction of the regurgitant jet was in a commissure in 2 patients, central in 6 patients, and eccentric and directed along the anterior leaflet of the mitral valve in 19 patients.
The patterns of cusp fusion in the 44 patients in whom echocardiograms were available for re-review were as follows: naturally perfect with no raphe (Sievers Type 0) in 4 (9%), right/left cusp fusion (Sievers Type 1, R/L) in 31 (71%), right/noncoronary cusp fusion (Sievers Type 1, R/N) in 8 (18%), and left/noncoronary cusp fusion (Sievers Type 1, L/N) in 1 (2%).
Measurements of aortic diameter at all levels in the entire cohort passed the normality test. Mean aortic diameter at the annulus was 28.1 ± 0.7 mm, and that at the diaphragmatic hiatus was 21.7 ± 0.4 mm. The largest aortic diameter was in the tubular portion of the ascending aorta, in which the mean diameter was 45.9 ± 1.0 mm. The aorta then tapered to normal diameter across the aortic arch; the mean diameter distal to the innominate artery was 30.1 ± 0.8 mm (
Figure 2, A). When compared with the caliber of either the proximal or distal descending aorta, ascending aortic and arch diameters were significantly larger (Figure 2, A).
|
Cluster analysis (
Figure 3) demonstrated 4 distinct patterns of aortic dilation in these patients with BAVs. Cluster I patients (n = 8) had involvement of the aortic root. Cluster II patients (n = 9) had involvement of the tubular portion of the ascending aorta. Cluster III patients (n = 18) had involvement of the tubular portion of the ascending aorta and transverse aortic arch. In these patients aortic diameters proximal and distal to the takeoff of the innominate artery were 46.3 ± 6.2 mm and 35.9 ± 4.8 mm, respectively. In cluster IV patients (n = 29) the aortic dilatation was most diffuse, involving the aortic root, ascending aorta, and the proximal aortic arch. Aortic diameter was 41.6 ± 6.5 mm at the sinuses of Valsalva, 46.7 ± 8.6 mm in the tubular ascending aorta, 36.2 ± 5.7 mm proximal to the innominate artery, and 29.1 ± 5.8 mm in the midarch. Cluster I contained the youngest patients and the highest proportion of female patients. Clusters I and IV, both of which had aortic root involvement, accounted for 73% of patients with a bovine aortic arch. The pattern of cusp fusion in each cluster is depicted in Figure 3, but cusp fusion pattern was not associated with any particular aortic morphology cluster pattern.
|
| Discussion |
|---|
|
|
|---|
Natural history observational studies have suggested that an ascending aortic diameter of 6 cm (irrespective of whether the valve is bicuspid or tricuspid) is an indication for surgical graft replacement, with 6 cm being the hinge point beyond which there is a 30% increase in the probability of rupture.17
Patients who underwent isolated aortic valve replacement when the aortic diameter exceeded 5.1 cm experienced a risk of aortic dissection in excess of 20% compared with 0.6% in patients with no ascending aortic dilatation.18,19
E. Stanley Crawford first brought to our attention this grave surgical error of omission more than 20 years ago. Patients with BAVs undergoing aortic valve replacement commonly have substantial dilation of the ascending aorta,20
which continues to enlarge after aortic valve replacement.21
Furthermore, patients with BAVs with moderate aortic dilatation who undergo only aortic valve replacement sustain aortic dissection, rupture, and sudden death more frequently than similar patients with a tricuspid aortic valve.22-24
Based on these findings, the American College of Cardiology and American Heart Association practice guidelines have now adopted a more aggressive posture, favoring aortic replacement when the aorta is larger than 45 mm in patients with BAVs undergoing aortic valve replacement and 50 mm in patients with BAVs with isolated thoracic aortic aneurysms.25
The extent of the aorta that should be replaced, however, presently is unknown. In the present study 58% of patients had aortic root involvement (clusters I and IV), and 73% of patients had involvement of the proximal arch (clusters III and IV). In the latter groups of patients, the aortic dilatation extended into the midarch in 35%. This question of how much aorta to replace highlights the importance of relative aortic size, as introduced by Davies and colleagues,26
or of observed aortic size indexed to predicted aortic size, as first advocated by Legget and associates.27
Although the latter is likely to be more reliable in predicting adverse clinical events, it depends on accurate reference values that presently do not exist for the aortic arch. Furthermore, the impetus to replace all diseased aortic segments must be balanced against any incremental operative risk inherent in a more aggressive surgical approach.
Two main surgical options exist for the treatment of aortic root aneurysms: composite valve graft (CVG) or valve-sparing aortic root replacement. Both approaches can be carried with low operative mortality and excellent long-term outcomes.28,29
Compilation of our own results in the 5-year period covered by this report has shown that 1 of 126 patients undergoing elective mechanical CVG has died (0.79% mortality rate). Similarly, none of the 106 patients undergoing elective reimplantation-type valve-sparing root replacement has died. Arguably, in young patients the more attractive option is valve-sparing aortic root replacement if the BAV cusps are not fibrotic or calcified, so that the patient avoids the thromboembolic and anticoagulant-related hemorrhagic complications of a CVG with a mechanical prosthesis. This approach, however, exposes the patient to a higher risk of reoperation when the valvular pathology progresses or the valve-sparing operation does not prove to be durable, but this increased risk is not clearly defined in the current literature. Another approach, which we do not recommend in this young patient population, is the separate valve graft, whereby the aortic valve and the supracoronary aorta are replaced separately. This procedure leaves diseased aortic sinuses behind and should only be undertaken when the patient is elderly and has significant comorbidity and is deemed to be unfit for a full aortic root replacement.
Total arch replacement is performed today with low morbidity and mortality in centers with experienced personnel.30
The decision for aortic arch replacement is made preoperatively on review of aortic imaging. The extent of resection then informs our choice of arterial cannulation. When aortic arch replacement is planned, patients either undergo cannulation of the axillary artery or the innominate artery. In all cases we use a combination of selective antegrade cerebral perfusion and hypothermia. Again, during the time interval of the present study, none of the 62 patients undergoing CVG and arch replacement and none of the 31 patients undergoing valve-sparing root replacement and arch replacement have died. However, it is realistic to expect some small increase in risk if the arch is replaced concomitantly at centers with less-experienced personnel. Despite this theoretic increased risk, we believe that total aortic arch replacement (frequently using the "peninsula technique," leaving a small tongue of greater curvature of the arch along the origins of the great vessels, which is more aggressive than the traditional beveled graft hemiarch replacement) should be carried out in the cluster III patients with BAVs whose aortas measure 46 mm just at the takeoff of the innominate artery. In patients in cluster IV, even an open distal anastomosis when replacing the ascending aorta will leave behind the proximal aortic arch, on average measuring 36 mm. Given that the ascending aorta in patients with BAVs enlarges by approximately 0.9 to 1.9 mm/y,31,32
it would take less than 15 years before the aortic arch would theoretically dilate to 50 mm. These more aggressive strategies are warranted given the young age of these patients with BAVs, averaging 45 years in our present cohort. Using less-extensive aortic replacement places these patients with an underlying aortopathy at risk of either aortic catastrophe, which is frequently fatal, or requirement for later reoperation, which is a high-risk redo procedure. The decision to carry out a more extensive resection ought to be taken in light of the personal outcomes of the treating team. Less-experienced surgeons might wisely elect to avoid complete resection of the diseased aortic segments.
Several limitations temper the inferences that can be drawn from the present analysis. First, we do not presently have clinical data to support the notion that more aggressive aortic replacement will decrease postoperative morbidity and mortality over the long-term. Indeed, the retrospective natural history studies regarding how malignant or benign thoracic aortic aneurysms behave in patients with BAVs are conflicting.22,23,31,33
Second, we did not have access to all echocardiograms for personal re-review, which rendered our analysis of cusp fusion patterns and patterns of aortic dilation relatively underpowered.
Third, our snapshot analysis does not provide any longitudinal information concerning the fate of aortic aneurysms in patients with BAVs. In fact, the different clusters could theoretically represent the same pathology along a continuum.
Fourth, this patient sample is a selected cohort in which we had access to complete CTA or MRA thoracic aortic imaging. We are also unable to determine the total number of patients with BAVs who were treated at our institution during the study interval. If all patients with BAVs were subjected to more complete thoracic aortic imaging, the degree and extent of aortic dilation might differ.
Fifth, our patient population was not compared with patients with ascending aortic aneurysms who had a trileaflet aortic valve; based on current information, it is unclear how aneurysm extent and morphology differ between these patient subgroups. Nevertheless, we must take to heart Dr John S. Child's plea that we must now abandon the terms "poststenotic dilation" and "postregurgitant dilation" in describing the dilated aorta that accompanies a BAV because these patients have an underlying connective tissue disorder and the aneurysmal dilation is not a consequence of the coexistent valvular hemodynamic abnormality.15
We conclude that aortic dilatation in patients with BAVs follows 4 distinctive patterns that militate for an individualized, custom-tailored degree of ascending aortic and arch replacement. Patients in clusters III and IV requiring operations should have the transverse arch replaced and not just the ascending aorta (along with concomitant root replacement in cluster IV). In cluster I patients complete aortic root replacement (reimplantation type valve-sparing or CVG) is necessary, whereas in cluster II patients a supracommissural ascending aortic graft is adequate. This individualized approach is our practice and should minimize the incidence of late aortic complications and need for reoperation.
| Figure E1 |
|---|
|
|
|---|
|
| Table E1 |
|---|
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ICC, Interclass correlation; 2-D, 2-dimensional; 3-D, 3-dimensional.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
H. J. Patel, C. Nguyen, A. C. Diener, M. C. Passow, D. Salata, and G. M. Deeb Open arch reconstruction in the endovascular era: Analysis of 721 patients over 17 years J. Thorac. Cardiovasc. Surg., June 1, 2011; 141(6): 1417 - 1423. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-H. Sievers and H. L. Sievers Aortopathy in bicuspid aortic valve disease -- genes or hemodynamics? or Scylla and Charybdis? Eur J Cardiothorac Surg, June 1, 2011; 39(6): 803 - 804. [Full Text] [PDF] |
||||
![]() |
E. Girdauskas, M. A. Borger, M.-A. Secknus, G. Girdauskas, and T. Kuntze Is aortopathy in bicuspid aortic valve disease a congenital defect or a result of abnormal hemodynamics? A critical reappraisal of a one-sided argument Eur J Cardiothorac Surg, June 1, 2011; 39(6): 809 - 814. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kourliouros, J. Grapsa, P. Nihoyannopoulos, and T. Athanasiou Modification of the Cabrol as a bailout procedure in complicated bicuspid valve aortopathy Interact CardioVasc Thorac Surg, February 1, 2011; 12(2): 199 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Schafers, T. Kunihara, P. Fries, B. Brittner, and D. Aicher Valve-preserving root replacement in bicuspid aortic valves J. Thorac. Cardiovasc. Surg., December 1, 2010; 140(6_suppl): S36 - S40. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Itoh, M. Fischbein, K. Arata, and D. C. Miller "Peninsula-Style" Transverse Aortic Arch Replacement in Patients With Bicuspid Aortic Valve Ann. Thorac. Surg., October 1, 2010; 90(4): 1369 - 1371. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Girdauskas, M. A. Borger, T. Kuntze, and M. D. Hope Aortopathy in Bicuspid Aortic Valve Disease: Is It Really Congenital? Radiology, September 1, 2010; 256(3): 1015 - 1016. [Full Text] [PDF] |
||||
![]() |
M. Boodhwani, L. de Kerchove, D. Glineur, J. Rubay, J.-L. Vanoverschelde, P. Noirhomme, and G. El Khoury Repair of regurgitant bicuspid aortic valves: A systematic approach J. Thorac. Cardiovasc. Surg., August 1, 2010; 140(2): 276 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Buchner, M. Hulsmann, F. Poschenrieder, O. W. Hamer, C. Fellner, R. Kobuch, S. Feuerbach, G. A. Riegger, B. Djavidani, A. Luchner, et al. Variable phenotypes of bicuspid aortic valve disease: classification by cardiovascular magnetic resonance Heart, August 1, 2010; 96(15): 1233 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. Nazer, A. M. Elhenawy, S. S. Fazel, L. E. Garrido-Olivares, S. Armstrong, and T. E. David The Influence of Operative Techniques on the Outcomes of Bicuspid Aortic Valve Disease and Aortic Dilatation Ann. Thorac. Surg., June 1, 2010; 89(6): 1918 - 1924. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Hope, T. A. Hope, A. K. Meadows, K. G. Ordovas, T. H. Urbania, M. T. Alley, and C. B. Higgins Bicuspid Aortic Valve: Four-dimensional MR Evaluation of Ascending Aortic Systolic Flow Patterns Radiology, April 1, 2010; 255(1): 53 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Rahimtoola The Year in Valvular Heart Disease J. Am. Coll. Cardiol., May 19, 2009; 53(20): 1894 - 1908. [Full Text] [PDF] |
||||
![]() |
A. Della Corte and M. Cotrufo Bicuspid aortopathy or bicuspid aortopathies? The risk in generalizing. J. Thorac. Cardiovasc. Surg., December 1, 2008; 136(6): 1604 - 1604. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |